Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3280 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2018-12-27 | 2019-01-23 | 70526 |
| TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-03-05 | 2019-05-21 | 77902 |
| TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-03-13 | 2019-05-21 | 78558 |
| TRI-CIRA LO 21 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-04-10 | 2019-08-26 | 80931 |
| TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-08-07 | 2019-08-26 | 91109 |
| TRI-CIRA LO 28 | 0.025MG 0.025MG 0.025MG 0.180MG 0.215MG 0.250MG | TABLET | Resolved | 2019-11-13 | 2019-11-18 | 98575 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2021-11-24 | 2021-12-24 | 149793 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2023-02-03 | 2023-04-17 | 183589 |
| APO-TRIMEBUTINE | 100MG | TABLET | Resolved | 2023-07-14 | 2023-08-14 | 198716 |
| ZAMINE 21 | 3.0MG 0.030MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 558 |
| ZAMINE 21 | 0.03MG 3MG | TABLET | Resolved | 2023-06-16 | 2023-07-27 | 195081 |
| ZAMINE 21 | 0.03MG 3MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210668 |
| ZAMINE 21 | 0.03MG 3MG | TABLET | Resolved | 2024-02-02 | 2024-03-29 | 218391 |
| ZAMINE 28 | 3.0MG 0.030MG | TABLET | Resolved | 2017-03-11 | 2020-09-04 | 561 |
| ZAMINE 28 | 3MG 0.03MG | TABLET | Resolved | 2021-02-12 | 2021-03-10 | 133984 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2023-09-07 | 2023-09-28 | 203831 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2023-11-24 | 2023-12-22 | 211487 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2024-01-26 | 2024-03-08 | 217475 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Resolved | 2025-08-28 | 2025-09-19 | 266081 |
| ZAMINE 28 | 0.03MG 3MG | TABLET | Actual shortage | 2025-10-30 | 2025-11-20 | 270732 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |